Oliver Kiddie – Managing Director – Legend Mining (ASX:LEG) is an Australian exploration company listed on the Australian Securities Exchange (ASX:LEG). Legend’s mission is to make value-adding mineral discoveries and utilise all available asset bases to maximise stakeholder benefit.
Copyright 2024 – Finance News Network
20 Sep 2024 - Prime Financial Group Limited (ASX:PFG) Managing Director, CEO and Chairman Simon Madder provides an update on the company, discussing drivers behind FY24 performance, the acquisitions of Altor Capital and Equity Plan Management, and outlook.
06 Sep 2023 - GBM Resources Limited (ASX:GBZ) Managing Director Peter Rohner provides an update on the company's projects, discussing the JV with Newcrest Mining (ASX:NCM) and recent divestments.
14 Mar 2024 - Delve into the cutting-edge realm of regenerative medicine with Kilian Kelly, CEO of Cynata Therapeutics. Learn how their stem cell innovations are shaping the future of healthcare.
17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an update on the its clinical trials.
01 Jul 2021 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO & Managing Director Dr Michael Baker discusses the company's acquisition of the invariant natural killer T (iNKT) cell therapy platform from Imperial College London.
27 May 2022 - TerraCom Limited (ASX:TER) Executive Chairman Craig Ransley discusses drivers behind the company's performance and share price over the previous year.
25 Jul 2024 - Stuart Crow - Non Executive Chairman - Lake Resources N.L. (ASX:LKE, OTC: LLKKF) is a responsible lithium developer utilising state of-the-art ion exchange extraction technology for production of sustainable, high purity lithium from its flagship Kachi Project in Catamarca Province within the Lithium Triangle in Argentina. Lake also has three additional early-stage projects in this region.
23 Dec 2019 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO, James McBrayer talks about the company's joint venture to expand Positron Emission Tomography (PET) diagnostics business opportunities for NSW and Australia.